Case studies

Case Study #1 - Value Optimization to Improve an Asset’s Commercial Potential, and Acquisition Attractiveness

The client was a pre-commercial, publicly traded biotechnology, with a small global pricing and market access team preparing for the global launch of an ultra-orphan, Phase III candidate.  The global market access team had limited EU expertise, was given an executive mandate to explore named patient programs…

Read more on this case study

Case Study #2 - Indication Sequencing to Drive Post-Launch Success

The company is undergoing rapid employee expansion, has a soaring stock price, and must meet investor expectations post-launch.  The lead asset was transitioning to Phase III, and was seeking two rare disease indications.  Each indication had a similar level of unmet need…

Read more on this case study

Case Study #3 - Pricing, and Market Access Business Development Services

casestudyA leading global biotechnology company with an extensive product portfolio, and strong cash position is actively seeking to grow their development pipeline through the acquisition of companies or assets that have promising commercial potential and/or are complimentary to their portfolio…

Read more on this case study